NYSE
HUM
Last Price
US $384.97
KEY FIGURES
MKT CAP
$46.2B
EPS
TTM
$10.63
EPS Growth (1Y)
-1.40%
PEG
TTM
-
P/E
TTM
36.21x
P/S
TTM
0.32x
YIELD
0.92%
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Humana Inc. cash flow to debt ratio of 7.12% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Free cash flow growth
Humana Inc.'s free cash flow has decreased 84.32% from $2.39B last year to $375.00M, signaling decreasing performance
Debt-to-equity ratio
Humana Inc.'s debt to equity ratio is 0.74, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Humana Inc.'s debt has decreased relative to shareholder equity from 0.75 last year to 0.74 today, signaling strengthened financials
Net debt to EBITDA
Humana Inc. has a net debt to EBITDA ratio of 3.00x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Interest coverage
Humana Inc.'s interest coverage ratio of 2.87 indicates that earnings with margin can cover interest payments on company debt
Profit margin growth
Humana Inc.'s profit margin has decreased (14.37%) in the last year from 1.02% to 0.88%, signaling decreasing performance
Current ratio
Humana Inc.'s short-term liabilities of $10.31B exceed its short-term assets of $7.47B, signaling financial risk
Return on assets
Humana Inc.'s return on assets of 2.23% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Humana Inc.'s return on equity of 6.91%, is lower than 15.00%, indicating bad performance
Earnings quality
Humana Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Earnings stability
Humana Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
Humana Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Humana Inc. has a free cash flow yield of 0.81%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
Humana Inc.'s yearly earnings has decreased 1.57% since last year from $1.21B to $1.19B, signaling decreasing performance
Revenue growth
Humana Inc.'s yearly revenue has increased 10.11% since last year from $117.76B to $129.66B, signaling increasing performance
Return on invested capital
ROIC 4.52% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
3-year revenue CAGR
Humana Inc.'s 3-year revenue CAGR of 11.75% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Humana Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Humana Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
Humana Inc. has insufficient data to evaluate this check.
Earnings yield (TTM)
Humana Inc. has an earnings yield of 2.76%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
EBITDA Valuation
Humana Inc. is overvalued relative to its fair value price of 96.35 based on EBITDA multiple model
EV/EBITDA (FY)
Humana Inc. has an EV/EBITDA ratio of 18.93x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
PEG ratio (TTM/FY)
Humana Inc.'s earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.
Price-to-book ratio (FY)
Humana Inc. has a price-to-book ratio of 2.40x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Humana Inc. has a price-to-sales ratio of 0.32x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
6.91%
Return on equity
ROIC: 4.52%
Valuation History
36.1X
Price to Earnings
EV/EBITDA: 17.5X
Cash flow
Profit margin
10.93%
EBITDA
-12.20%
Cash flow
-39.63%
Cash Flow (DCF)
Fair Value
Market $384.97
—
Default assumptions
EBITDA Multiple
Fair Value
Market $384.97
-74.97%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.